With FDA approval, Genentech turns eye implant's focus to diabetes
Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...
Insurer Denies Access To Drugs Granted Accelerated Approval By FDA
Going forward, we may see more instances in which insurers deny or (temporarily) severely restrict coverage of accelerated ...
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
The Food and Drug Administration approved the pill from Vertex Pharmaceuticals for acute pain that often occurs after surgery ...
The American Journal of Managed Care3d
OIG Report Seeks Better Oversight, Records for FDA’s Accelerated Approvals
Amid the uproar over the firing of 18 inspectors general, a report offering a coda to the aducanumab approval episode has ...
Supernus: New Approval Holds Promise Of Increased Growth
Supernus Pharmaceuticals' FDA approval for ONAPGO in Parkinson's Disease offers optimism despite past challenges, with a ...
Mastering Medicare Advantage Prior Authorization: Tips to Accelerate Your Approval
Understanding the reasoning and process of Medicare Advantage prior authorization can help you gain faster approval for a required prior authorization.
Scientists Hope to Slow Dog Ageing With New Experimental Drug: Here's More About It
The STAY study aims to change this reality. Researchers hope that the new drug will slow down the ageing process, improve ...
How a Leftist Activist Group Helped Torpedo a Psychedelic Therapy
The fallout from the F.D.A.’s rejection of MDMA-assisted treatment for PTSD worries researchers and experts who fear other ...
AOL5d
Is Vertex Pharmaceuticals a Buy Now That the FDA Approved Its New Pain Drug?
At the end of 2024, more than 50 authorized treatment centers in the U.S. had initiated the treatment process with over 50 patients. In December, the FDA approved Alyftrek, a new once-daily pill ...
FDA approves new type of nonopioid painkiller for acute pain
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
Moscow-Pullman Daily News5d
The story of food additives and banning of Red Dye No. 3
You may have heard in the news that the U.S. Food and Drug Administration will no longer allow the use of FD&C Red Dye No. 3 ...
Arquitos Capital Management Q4 2024 Commentary
Arquitos returned 29.6% net of fees and expenses in 2024, compared to 25.0% for the S&P 500. Click here to read the full ...